Manufacturing Units & Portfolio
With manufacturing sites approved by the EU and US FDA, Medicamen is well-positioned to serve regulated markets. They serve as the foundation for Medicamen’s expanding role in global product development and innovation.
Strategically located R&D and manufacturing facilities are the backbone of Medicamen’s ability to scale, uphold uncompromising quality, and move with agility across its pharmaceutical business. This integrated footprint positions the Company to meet global demand with speed and confidence, while maintaining the highest standards of safety, precision, and performance.
Location 1
Bhiwadi, Rajasthan
Facility Details
- 21,000 sq. ft. area
- Six-block contemporary facility for general formulations
- Dedicated R&D block for formulation
Certifications
- EU GMP (Greece)
- WHO GMP
- ISO
Location 2
Haridwar Unit I, Uttarakhand (General)
Facility Details
- 210,000 sq. ft. area
- Focused on general formulations across finished dose forms
- World-class integrated quality control lab
Certifications
- WHO GMP
Location 3
Haridwar Unit II, Uttarakhand (Oncology)
Facility Details
- 350,000 sq. ft. area
- State-of-the-art facility dedicated to oncology
- Specialized lines for highly potent and lyophilized formulations
Certifications
- US FDA Approved
- WHO GMP
Location 4
R&D Facility at Bhiwadi (Rajasthan)
Facility Details
- 12,000 sq. ft. operations with ₹40 Cr. investments
- 60 scientists & pharmacists driving new formulations
- Approved by the Department of Scientific & Industrial Research (DSIR)
Certifications
- DSIR Approved
Location 5
Agro-chemical Facility at Dehradun (Uttarakhand)
Facility Details
- Annual capacity of 1,450 MT
- 95% capacity utilization across formulations
- Skilled workforce of 200+ associates
Certifications
- ISO 9001:2015
Location 6
Pharma API Facility: Onco & Non-Onco at Dahej-II (Gujarat)
Facility Details
- US FDA-approved facility
- Spread across 50,000 sq. ft. with 30 KL reactor capacity
- Dedicated lines for both oncology and non-oncology production
- Expansion underway with a dedicated R&D block
Certifications
- US FDA Approved
Location 7
Agro & Specialty Chemical Facility at Dahej-III (Gujarat)
Facility Details
- Commercial operations commencing September 2024
- 2,000 MT per annum capacity designed for insecticides & fungicides
- Purpose-built for formulation manufacturing and scale-up
Certifications
- Designed for ISO 9001:2015